BTLA, CD27, CD28, CD40, CD80/B7-1, CD86/B7-2, CTLA-4, GITR, GITRL, HVEM, ICOS, LAG-3, PD-1, PD-L1, PD-L2, TIM-3, TLR-2
CIRC
-
-
-
Use this panel to investigate T cell activation and exhaustion, and to provide supportive information for assessing the potential suitability of checkpoint inhibitor therapies in cancer and autoimmune conditions.